|
| Exchange Disseminated Time | Venus Remedies Ltd has informed BSE that Venus Remedies "Vancoplus" gets Patent from Australia.
Annouvement:
"The Company has added one more patent to its kitty for “Vancoplus’, a novel antibiotic formulation to combat Methicillin Resistant Staphylococcus Aureus ( MRSA ) infections. After Potentox, this is company’s second patent grant from the Australian Patent office (APO), Government of Australia, and is valid till February 2026." (For more details kindly refer Corporate Announcements on www.bseindia.com).
|
|
|